SPDR S&P Pharmaceuticals ETF
XPH
XPH
73 hedge funds and large institutions have $115M invested in SPDR S&P Pharmaceuticals ETF in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
16% less capital invested
Capital invested by funds: $138M → $115M (-$22.7M)
31% less call options, than puts
Call options by funds: $957K | Put options by funds: $1.38M
Holders
73
Holding in Top 10
–
Calls
$957K
Puts
$1.38M
Top Buyers
| 1 | +$4.99M | |
| 2 | +$2.4M | |
| 3 | +$2.23M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.09M |
Top Sellers
| 1 | -$25.8M | |
| 2 | -$9.22M | |
| 3 | -$4.05M | |
| 4 |
TCA
Taconic Capital Advisors
New York
|
-$1.66M |
| 5 |
AWM
AE Wealth Management
Topeka,
Kansas
|
-$615K |